Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Inari Medical Inc (NQ: NARI )

55.53 +0.63 (+1.15%)
Streaming Delayed Price Updated: 3:04 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Why Shares of Inari Medical Are Up Thursday
The company announced second-quarter earnings. 
Via The Motley Fool
Looking Into Inari Medical's Return On Invested Capital
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally 
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Closes Acquisition of LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
After blowout earnings, Integer may be headed to new highs
A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024. 
Via MarketBeat
Topics Economy
Exposures Supply Chain
Inari Medical: Q1 Earnings Insights
Via Benzinga
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
Inari Medical Reports Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
2 Top Healthcare Stocks I'd Buy Now Without Hesitation
Whether you're seeking dividends or explosive growth, the economy's most reliable sector has something for you. 
Via The Motley Fool
Inari Medical Stock Gained 21% on Thursday - Here's Why It Soared
Inari Medical Inc (NASDAQ: NARI) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the  
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90... 
Via Benzinga
Inari Medical Reports Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism
From Inari Medical, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Inari Medical Announces the Release of 2022 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.